AU2018257307B2 - Hematopoietic progenitor cell marker - Google Patents

Hematopoietic progenitor cell marker Download PDF

Info

Publication number
AU2018257307B2
AU2018257307B2 AU2018257307A AU2018257307A AU2018257307B2 AU 2018257307 B2 AU2018257307 B2 AU 2018257307B2 AU 2018257307 A AU2018257307 A AU 2018257307A AU 2018257307 A AU2018257307 A AU 2018257307A AU 2018257307 B2 AU2018257307 B2 AU 2018257307B2
Authority
AU
Australia
Prior art keywords
positive
cells
antibody
fraction
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2018257307A
Other languages
English (en)
Other versions
AU2018257307A1 (en
Inventor
Suguru ARIMA
Akira Hayashi
Shoichi Iriguchi
Shin Kaneko
Yoshiaki KASSAI
Yuta MISHIMA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Kyoto University NUC
Original Assignee
Takeda Pharmaceutical Co Ltd
Kyoto University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Co Ltd, Kyoto University NUC filed Critical Takeda Pharmaceutical Co Ltd
Publication of AU2018257307A1 publication Critical patent/AU2018257307A1/en
Application granted granted Critical
Publication of AU2018257307B2 publication Critical patent/AU2018257307B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C12N5/0638—Cytotoxic T lymphocytes [CTL] or lymphokine activated killer cells [LAK]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657—Cardiomyocytes; Heart cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/505—CD4; CD8
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/11—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Transplantation (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2018257307A 2017-04-26 2018-04-25 Hematopoietic progenitor cell marker Active AU2018257307B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2017-087723 2017-04-26
JP2017087723 2017-04-26
PCT/JP2018/016864 WO2018199186A1 (ja) 2017-04-26 2018-04-25 造血前駆細胞マーカー

Publications (2)

Publication Number Publication Date
AU2018257307A1 AU2018257307A1 (en) 2019-11-21
AU2018257307B2 true AU2018257307B2 (en) 2024-11-07

Family

ID=63918584

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2018257307A Active AU2018257307B2 (en) 2017-04-26 2018-04-25 Hematopoietic progenitor cell marker

Country Status (13)

Country Link
US (1) US20210102167A1 (https=)
EP (1) EP3617307A4 (https=)
JP (2) JP7430877B2 (https=)
KR (1) KR102803233B1 (https=)
CN (1) CN110691843B (https=)
AU (1) AU2018257307B2 (https=)
BR (1) BR112019022288A2 (https=)
CA (1) CA3061289A1 (https=)
EA (1) EA201992483A1 (https=)
IL (1) IL270126B2 (https=)
SG (1) SG11201909795RA (https=)
TW (1) TWI860972B (https=)
WO (1) WO2018199186A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250230411A1 (en) 2022-03-23 2025-07-17 Kyoto University Method for producing regulatory t cells
WO2023247722A1 (en) * 2022-06-22 2023-12-28 Fondazione Telethon Ets Method for isolating hemogenic endothelial cells
JPWO2024071010A1 (https=) 2022-09-26 2024-04-04
WO2024152926A1 (zh) * 2023-01-18 2024-07-25 深圳市人民医院 造血祖细胞的谱系及其命运决定基因的鉴定及应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016168586A1 (en) * 2015-04-16 2016-10-20 The Board Of Regents, The University Of Texas System Cd133+ cells and method for expanding
WO2017004127A1 (en) * 2015-06-29 2017-01-05 The General Hospital Corporation Embigin inhibition for promotion of hematopoietic stem and progenitor cell expansion

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8034613B2 (en) 2005-06-01 2011-10-11 Wisconsin Alumni Research Foundation Multipotent lymphohematopoietic progenitor cells
WO2011041912A1 (en) 2009-10-09 2011-04-14 University Health Network Self-renewing single human hematopoietic stem cells, an early lymphoid progenitor and methods of enriching the same
CN104053769A (zh) * 2011-11-21 2014-09-17 大学健康网络 造血祖细胞群体和富集其干细胞的方法
WO2015163185A1 (ja) * 2014-04-24 2015-10-29 学校法人関西医科大学 ヒト造血幹細胞濃縮画分の製造方法
EP3219791A4 (en) 2014-11-13 2018-07-18 Kyoto University Method for induction of t cells from pluripotent stem cells
CA3003152A1 (en) * 2015-11-04 2017-05-11 Fate Therapeutics, Inc. Methods and compositions for inducing hematopoietic cell differentiation
US10350873B2 (en) 2015-11-11 2019-07-16 Xerox Corporation System and method for removing support structure from three-dimensional printed objects using microwave energy and nanoparticles
EP3476934A4 (en) 2016-06-23 2020-02-26 Kyoto University METHOD FOR PRODUCING CD4 / CD8 POSITIVE DUAL T CELLS

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016168586A1 (en) * 2015-04-16 2016-10-20 The Board Of Regents, The University Of Texas System Cd133+ cells and method for expanding
WO2017004127A1 (en) * 2015-06-29 2017-01-05 The General Hospital Corporation Embigin inhibition for promotion of hematopoietic stem and progenitor cell expansion

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Schroeder MA et al, "Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft", Blood, 2017, 129(19):2680-2692, doi: 10.1182/blood-2016-09-739722, Epub 14 March 2017 *

Also Published As

Publication number Publication date
CN110691843B (zh) 2023-10-20
BR112019022288A2 (pt) 2020-05-19
SG11201909795RA (en) 2019-11-28
KR102803233B1 (ko) 2025-05-07
JP2023164892A (ja) 2023-11-14
JP7610817B2 (ja) 2025-01-09
WO2018199186A1 (ja) 2018-11-01
US20210102167A1 (en) 2021-04-08
IL270126A (en) 2019-12-31
NZ758956A (en) 2024-11-29
EP3617307A1 (en) 2020-03-04
TWI860972B (zh) 2024-11-11
TW201843301A (zh) 2018-12-16
IL270126B1 (en) 2024-12-01
EA201992483A1 (ru) 2020-03-06
AU2018257307A1 (en) 2019-11-21
CN110691843A (zh) 2020-01-14
JPWO2018199186A1 (ja) 2020-05-14
EP3617307A4 (en) 2021-01-27
IL270126B2 (en) 2025-04-01
CA3061289A1 (en) 2019-10-23
JP7430877B2 (ja) 2024-02-14
KR20200002909A (ko) 2020-01-08

Similar Documents

Publication Publication Date Title
US11578310B2 (en) Method for producing CD4/CD8 double-positive T cells
JP6529541B2 (ja) 幹細胞よりナチュラルキラー細胞を発生させる方法
KR102857712B1 (ko) 면역 세포로의 만능 줄기 세포의 지정된 분화 방법
US10660915B2 (en) Method for induction of T cells from pluripotent stem cells
JP7610817B2 (ja) 造血前駆細胞マーカー
US20200263139A1 (en) Methods for directed differentiation of pluripotent stem cells to hla homozygous immune cells
KR20150126943A (ko) 규정된 조건하에서 인간 만능성 줄기 세포의 조혈내피세포 분화를 위한 방법 및 재료
US20210238550A1 (en) METHOD FOR PRODUCING REGENERATED T CELL POPULATION VIA iPS CELLS
EP3693456A1 (en) Production method for ips cell-derived genetically diverse t cell colony
KR20240005792A (ko) B 계통 세포의 분화 및 확장을 위한 조성물 및 방법
HK40020008A (en) Hematopoietic progenitor cell marker
JP2024525910A (ja) 多能性幹細胞から免疫細胞の集団を作製する方法
US20220233665A1 (en) Medicinal composition
EA045419B1 (ru) Маркер гемопоэтических клеток-предшественников
US20250332259A1 (en) Thymic epithelial cell production method

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)